Author:
Ng D. P. K.,Tai B. C.,Koh D.,Tan K. W.,Chia K. S.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference77 articles.
1. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. US (2003) Renal data system annual data report: atlas of end-stage renal disease in the United States
2. Singapore Renal Registry (1997) First report of the Singapore Renal Register
3. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329:1456–1462
4. Jacobsen P, Rossing K, Rossing P et al (1998) Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy. Kidney Int 53:1002–1006
5. Penno G, Chaturvedi N, Talmud PJ et al (1998) Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM. Diabetes 47:1507–1511
Cited by
109 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献